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200a Monday, February 9, 2015determine whether myofilaments activated with ADP (without Ca) are sensitive
to kinase treatment.
Results:We show thatADP, in the absence ofCa, accelerates cross-bridge cycling
and force development in cardiomyocytes from HF patients, which was sensitive
to PKA-mediated phosphorylation (i.e. decreased sensitivity to ADP). Ca-
sensitivity increased in the presence of increasing [ADP] and was accompanied
by significant slowing cross-bridge cycling kinetics. This was correlatedwith sig-
nificant increases in residual force enhancement (i.e. high initial tension recovery).
Conclusions: The current data show that high [ADP] reduces the ability to
desensitize myofilaments to Ca, which likely compromises restoration of
end-diastolic length. High ADP increased cross-bridge strain (i.e. diastolic
dysfunction) and depressed myofilament cycling kinetics, which may limit
muscle shortening (i.e. systolic dysfunction). The present study suggests that
inability to lower myocardial ADP levels can be a primary determinant of con-
tractile dysfunction and disease progression in human HF.
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Myocardial Strain RateModulates the Speed of Relaxation in Dynamically
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Slow myocardial relaxation is an important clinical problem in about 50% of
patients who have heart failure. Prior experiments had suggested that the
slow relaxation might be a consequence of high afterload (hypertension) but
large clinical trials testing this hypothesis have failed; lowering blood pressure
in patients who have heart failure with preserved ejection fraction does not help
clinical outcomes. We performed new experiments using mouse, rat, and hu-
man trabeculae (Chung et al., Biophys J. 106,564a, 2014) and showed that it
is not afterload but the strain rate at end systole that determines the subsequent
speed of relaxation. To investigate the molecular mechanisms that drive this
behavior, we ran simulations of our mechanical experiments using the freely
available software MyoSim (http://www.myosim.org). This software simulates
the mechanical properties of dynamically activated half-sarcomeres by extend-
ing A.F.Huxley’s cross-bridge distribution technique with calcium activation
and cooperative effects. We discovered that our experimental data could be
reproduced using a relatively simple framework consisting of a single half-
sarcomere pulling against a series elastic spring. Further analysis of the simu-
lations suggested that quick stretches speed myocardial relaxation by detaching
myosin heads and thereby disrupting the cooperative mechanisms that would
otherwise prolong thin filament activation. The simulations therefore identify
myofilament kinetics and tissue strain rate as potential therapeutic targets for
heart failure attributed to slow relaxation.
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Myosin MgADP Release Rate Decreases at Longer Sarcomere Length to
Prolong Myosin Attachment in Skinned Rat Myocardial Strips
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Cardiac contractility increases as sarcomere length (SL) increases, suggesting
that intrinsic molecular mechanisms underlie the Frank-Starling relationship
to confer increased cardiac output with greater ventricular filling. Myosin’s ca-
pacity to generate force is Ca2þ-regulated by thin-filament proteins and sarco-
mere length, which dictates the number of potential actin-myosin cross-bridge
interactions. One mechanism underlying greater cardiac contractility at longer
SL could involve longer myosin attachment duration (ton). To test this idea, we
used stochastic length-perturbation analysis in skinned rat papillary muscle
strips to measure ton as [MgATP] varied (0.05-5 mM) at 1.9 and 2.2 mm SL.
From this ton-MgATP relationship, we calculated cross-bridge MgADP release
rate (k-ADP) and MgATP binding rate (kþATP). As MgATP increased ton
decreased hyperbolically for both SL, but ton was roughly 50% longer for
2.2 vs. 1.9 mm SL at each [MgATP] (2553 vs. 1651 ms at 5 mM MgATP,
17 C, p<0.05). These ton differences arose from slower k-ADP at 2.2 mm SL
(4253 vs. 7458 s1, p<0.001), as MgATP binding rates did not differ with
SL (281556 vs. 327593 mM1 s1). Absolute tension values were greater
at 2.2 vs. 1.9 mm SL for relaxed (4.450.7 vs. 0.850.2 kPa at pCa 8.0,
p<0.001) and maximally activated (20.051.4 vs. 14.251.6 kPa at pCa 4.8,
p<0.001) conditions, and the force-pCa relationship was more sensitive to
Ca2þ at 2.2 mm SL (pCa50¼5.4550.01 vs. 5.3650.01, p<0.05). These
increased tension values suggest that cross-bridges may bear greater loads at
longer SL, which diminishes MgADP release to prolong ton and amplify coop-
erative cross-bridge contributions to thin filament activation. Therefore, load-
dependent rates of the actomyosin cross-bridge cycle may vary with SL to
contribute, in part, to the Frank-Starling relationship in the heart.1004-Plat
Inherent Force-Dependent Properties of b Cardiac Myosin Contribute to
the Force-Velocity Relationship of Cardiac Muscle
Michael J. Greenberg, Henry Shuman, E. Michael Ostap.
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The cardiac cycle is a tightly regulated process in which the heart generates po-
wer during systole and relaxes during diastole. Appropriate power must be
generated to effectively pump blood against cardiac afterload. Dysfunction
of this cycle has devastating consequences for affected individuals. Cardiac po-
wer output is regulated by several feedback mechanisms (e.g. neuronal, hor-
monal, mechanical) which ultimately lead to changes in the force and power
output of the molecular motor, b-cardiac myosin (bCM). Despite its importance
in driving and regulating cardiac power output, the effect of force on the
contractility of a single bCM has not been measured at physiological [ATP].
Using optical trapping techniques, we found that similar to some other myosins,
bCM has a two-substep working stroke where the second mechanical substep is
associated with ADP release. At saturating [ATP] (4 mM), forces that resist the
power stroke slow myosin-driven contraction, suggesting that the inherent
properties of myosin contribute to the force-velocity relationship in muscle
and play an important role in the regulation of cardiac power output. Based
on our results and kinetic modeling, we propose that force inhibits the mechan-
ical transition associated with ADP release, leading to slowing of the rate of
ADP release, the same kinetic step that limits muscle shortening. These results
have important implications for cardiac diseases which affect power output,
such as heart failure and cardiomyopathies. This work was supported by the
American Heart Association (14SDG18850009 to M.J.G.) and National Insti-
tutes of Health (R01GM057247 to E.M.O. and K99HL123623 to M.J.G.).
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A significant number of cardiac myopathies in children and adults are caused
by mutations in the cMyBP-C gene. In disease, cardiac output is compromised
by altered cardiac muscle fiber contractility due to modulated interactions be-
tween cMyBP with actin or with S2. Comparative measurements in WT and
knockout mice (cMyBP-C-/-) muscle fibers have showed increased isotonic
shortening velocity, power output and rate of force redevelopment in absence
cMyBP-C. Thus, change of only a few amino acids in mutant cMyBP-C, espe-
cially in regions rich with phosphorylation sites, may cause significant change
in dynamics of muscle contractility. Comparison of measured sliding velocities
of actin filaments over the regions of myosin filament with and without
cMyBP-C in motility assays have provided molecular insight how these struc-
tural changes alter the kinetics of the interactions of cMyBP-C with myosin and
actin filaments. We used a multi-scale, computational modelling platform,
MUSICO, (MUscle SImulation COde) to assess the effect of cMyBP-C muta-
tions on sarcomere contraction. This platform includes explicit 3-D sarcomere
structures, extensible actin and myosin filaments, various models for the acto-
myosin cycles, thin filament regulation via a continuous flexible chain (CFC)
model and now cMyBP-C using the kinetic parameters for dynamically form-
ing and disrupting connections between cMyBP-C and actin, derived from the
motility studies. We compared the model predictions between different muta-
tions and the corresponding mechanical experiments. The predictions from
cMyBP-C sarcomeric model showed significant differences between the mu-
tants, and closely followed observations. This results allow the quantitative
evaluation of the role of cMyBP-C in the regulation of sarcomere structure
and function, the development of a multi-scale myoarchitectural representation
of disease phenotype and the creation of a novel diagnostic and prognostic
methodology for tracking disease progression in patients.
Supported by: R01s AR048776 and DC 011528
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Monday, February 9, 2015 201aMutations in MYBPC3, the gene encoding the muscle regulatory protein car-
diac myosin binding protein-C (cMyBP-C), are among the most common
causes of hypertrophic cardiomyopathy (HCM) in both people and cats. How-
ever, despite the high prevalence of mutations in MYBPC3, relatively little is
understood regarding how mutations lead to disease. One possibility is that
some point mutations alter cMyBP-C protein structure leading to enhanced
degradation and elimination of the mutant protein. If levels of cMyBP-C pro-
tein expression are reduced, then haploinsufficiency (lack of sufficient protein)
can trigger disease. Here we tested this idea by analyzing the impact of the
A31P mutation, linked to HCM in Maine Coon cats, on 1) the in vitro protein
structure of the C0 domain of cMyBP-C, and 2) the total protein expression of
cMyBP-C in myocardium of aged cats heterozygous for the A31P mutation. In
vitro results demonstrated that the A31P mutation disrupts folding of the C0
domain as shown by three independent methods: altered epitope recognition
onWestern blots; changes in sensitivity to proteolytic degradation; and reduced
b-sheet content assessed by circular dichroism. Western blots of endogenous
cMyBP-C obtained from myocardial samples also suggested that C0 structure
is altered in vivo because an antibody that preferentially recognizes C0 reacted
less with A31P cMyBP-C compared to wild-type cMyBP-C. However, despite
these significant structural differences, the A31P cMyBP-C was incorporated
into sarcomeres and total cMyBP-C protein (wild-type plus mutant) was similar
in wild type and heterozygous A31P cats. These results suggest that despite
protein folding abnormalities, the A31P mutation does not lead to haploinsuf-
ficiency in the population of older heterozygous cats studied here. Supported by
NIH R21HL093603.
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Myosin heavy chain 7 (MYH7) mutations are associated with familial cardio-
myopathies (FCM) and result in a high rate of sudden cardiac death. Human
induced pluripotent stem cells derived cardiomyocytes (hiPSC-CMs) have
recently shown promise as a model for studying FCM. We identified a cohort
with familial cardiomyopathy (FCM) associated with a MYH7 mutation
(E848G) and middle-age onset of systolic dysfunction and arrhythmias.
hiPSC-CMs from patient affected (FCM-CMs) and non-affected (WT-CMs)
individuals were generated from skin fibroblasts. Here we report, for the
first time, contractile properties of isolated myofibrils from these cultured
hiPSC-CMs for comparison using cultured cells and 3D engineered cardiac
tissue (3D-ECT) constructs. Isolated myofibrils were obtained from dif-
ferentiation day 20 hiPSC-CMs that were replated onto fibronectin-coated
nanopatterned cover slides and matured in culture for an additional 60 days
to obtain elongated and aligned myofibrils. This procedure produced hiPSC-
CMs that were usually > 100þ mm in length. hiPSC- FCM-CMs and WT-
CMs were harvested and skinned in a rigor solution containing 1% Triton
and contractile properties of single or small bundles of myofibrils were
measured in a custom built apparatus with rapid solution switching capabil-
ities. During maximal calcium activation FCM-CM myofibrils produced
approximately half the amount of force of WT-CM myofibrils, but prelimi-
nary data suggests no differences in the kinetics of force development or
relaxation. This compares well with 50 day cardiomyocytes plated on nano-
patterned surfaces or seeded into 3D-ECT constructs, where shortening and
force (respectively) of FCM-CMs was much less than for WT-CMs, with
no difference in calcium transient amplitudes. We speculate this early stage
contractile deficit may contribute to disease development and conclude
hiPSC-FCM-CMs can be a viable model for mechanical studies of cardiomy-
opathies in vitro.
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CA, USA.We have created a computational model of cardiac thin filament regulation that
includes a representation of the troponin I inhibitory region (or inhibitory pep-
tide, IP) and its binding interactions with actin. According to a canonical view
of thin filament activation, IP-actin binding prevents movement of tropomyosin
out of its blocked position under low Ca2þ conditions. Ca2þ binding to troponin
C (TnC) causes dissociation of the IP from actin, and permits tropomyosin tran-
sition. Instead of assuming that IP-actin interactions are infinitely strong in the
absence of Ca2þ, our model allows some spontaneous IP-actin dissociation. We
have used the energetic cost of Ca2þ-free dissociation (DG) as a free parameter
to determine whether the model can recapitulate changes to the IP. For instance,
lowering DG while keeping all other model parameters constant increases the
Ca2þ sensitivity of steady-state force in model simulations. These model results
closely resemble experiments in which the IP is mutated (T144P; Tachampa et
al., Circ Res 101:1081, 2007). We hypothesize that alterations to the IP in the
form of cardiomyopathic mutations or phosphorylation have the ability to tune
the dynamic Ca2þ sensitivity of cardiac muscle, altering the magnitude and
time course of twitches. Twitch simulations demonstrate that lowering DG
from infinity to 6.75 kJ/mol increases the magnitude and duration of contrac-
tion by 17 and 20%, respectively. These results suggest that twitch dynamics
can be modified substantially by the energy of IP-actin binding. They further
suggest that the model can be used to explore the effects of IP mutations and
posttranslational modifications.Platform: Protein Lipid Interactions II
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We propose a new topology of a bacterial membrane protein that serves to
sense changes in mechanical bilayer properties and, through interactions with
a potassium ion channel, to trigger biofilm formation (1). The membrane-
associated protein MstX (2) from Bacillus subtilis self-inserts into lipid bilayers
in such a way that its four helices lie parallel to the bilayer plane, with two he-
lices residing in each of the two apposing lipid headgroup regions. This topol-
ogy suggests a functional role of the protein as a modular entity for sensing
membrane properties such as bilayer thickness and hydration, as indicated by
a combination of different optical-spectroscopic techniques probing protein
structure and dynamics as a function of the effective hydrophobic diameter
of the membrane core. Accordingly, increasing membrane thickness or
decreasing membrane hydration results in a loosening of the helical-bundle
structure of MstX, which, through physical but noncovalent contacts, affects
the open probability or the single-channel conductance of YugO, a hitherto un-
characterised potassium ion channel essential for biofilm formation that is en-
coded in the same bicistronic operon as MstX (3). Leakage of potassium ions
through YugO finally initiates known signal transduction cascades that result
in the derepression of a set of genes required for biofilm formation.
References:
(1) Broecker et al. J. Am. Chem. Soc. 2014, accepted, DOI 10.1021/ja5064795
(2) Roosild et al. Science 2005, 307, 1317
(3) Lundberg et al. PLoS One 2013, 8, e60993
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Pathogenic Neisseria gonorrhoeae, the causative agent of gonorrhea, possess a
family of outer membrane proteins referred to as opacity-associated (Opa) pro-
teins. These Opa proteins are b-barrel outer membrane proteins that bind to hu-
man host cell receptors, inducing engulfment of the bacterium. To date, there
have been over 300 distinct opa alleles sequenced. The differences in sequence
have stemmed primarily from recombination events, and are most pronounced
in two regions of the protein in the second and third extracellular loops (termed
hypervariable regions, HV1 and HV2). These HV regions are responsible for
determining receptor specificity. The most abundant Opa family engages hu-
man CEACAM receptors (carcino-embryonic antigen-like cellular adhesion
molecules). While the Opa protein family has conserved structural elements,
the molecular determinants of the receptor interactions are unknown. We
